48,874
edits
Line 15: | Line 15: | ||
| Gross = | | Gross = | ||
| Grossing = | | Grossing = | ||
| Site = | | Site = [[lung]] - see ''[[lung tumours]]'' | ||
| Assdx = | | Assdx = | ||
| Syndromes = | | Syndromes = | ||
| Clinicalhx = [[smoking]] - usually a long history, heavy | | Clinicalhx = [[smoking]] - usually a long history, heavy | ||
| Signs = | | Signs = +/-hemoptysis | ||
| Symptoms = | | Symptoms = | ||
| Prevalence = not common | | Prevalence = not common | ||
| Bloodwork = | | Bloodwork = | ||
| Rads = | | Rads = lung mass, usu. central location | ||
| Endoscopy = | | Endoscopy = | ||
| Prognosis = poor | | Prognosis = poor | ||
Line 45: | Line 45: | ||
Precursor lesion - uncommonly seen: | Precursor lesion - uncommonly seen: | ||
*Pulmonary neuroendocrine cell hyperplasia.<ref name=pmid20943645>{{Cite journal | last1 = Travis | first1 = WD. | title = Advances in neuroendocrine lung tumors. | journal = Ann Oncol | volume = 21 Suppl 7 | issue = | pages = vii65-71 | month = Oct | year = 2010 | doi = 10.1093/annonc/mdq380 | PMID = 20943645 }}</ref> | *Pulmonary neuroendocrine cell hyperplasia.<ref name=pmid20943645>{{Cite journal | last1 = Travis | first1 = WD. | title = Advances in neuroendocrine lung tumors. | journal = Ann Oncol | volume = 21 Suppl 7 | issue = | pages = vii65-71 | month = Oct | year = 2010 | doi = 10.1093/annonc/mdq380 | PMID = 20943645 }}</ref> | ||
Clinical: | |||
*+/-Hemoptysis. | |||
==Gross== | ==Gross== |
edits